Research Project
Grant-in-Aid for Scientific Research (B)
The antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL). Tissue factor (TF), the major initiator of the coagulation system, is induced on monocytes by aPL in vitro, explaining, in part, the pathophysiology in this syndrome. However, little is known regarding the nature of the aPL-induced signal transduction pathways leading to TF expression. In this study, we investigated aPL inducible genes in peripheral blood mononuclear cell (PBMC) using cDNA array system and real time polymerase chain reaction (PCR). Our results indicated that the mitogen-activated protein kinase (MAPK) pathway was related to TF expression when PBMCs were treated, in the presence of β_2Glycoprotein I (β_2GPI), with human monoclonal anti-β_2GPI antibodies (β_2GPI dependent anticardiolipin antibodies ; aCL/β_2GPI). Western blotting studies using monocyte cell line (RAW264.7) demonstrated that p38 MAPK protein was phosphorylated with NF-κB (nuclear factor κ B) activation by monoclonal aCL/β_2GPI treatment, and that SB203580, a specific p38 MAPK inihibitor, decreased the aCL/β_2GPI-induced TF mRNA expression. The p38 MAPK phosphorylation, NF-κB translocation and TF mRNA expression triggered by aCL/β_2GPI were abolished in the absence of β_2GPI. These results demonstrated that the p38 MAPK signaling pathway plays an important role in aPL-induced TF expression on monocytes and suggest that the p38 MAPK may be a possible therapeutic target to modify a prothrombotic state in patients with APS.
All 2005 2004 Other
All Journal Article (19 results) Book (3 results) Publications (7 results)
Arthritis Rheum 51:2
Pages: 212-218
Hum Mol Genet 13:2
Pages: 171-179
Clin Immunol 112
Pages: 144-149
J Immunol 173
Pages: 5095-5102
Blood 103:10
Pages: 3766-3772
J Clin Immunol 23:5
Pages: 375-375
Am J Hum Genet 74
Pages: 466-471
J Dermatol Sci 34
Pages: 195-200
Clin Exp Dermatol 29
Pages: 91-92
J Invest Dermatol 122
Pages: 1225-1234
J Biol Chem 279
Pages: 1676-1683
J Crin Immunol 23:5
Br J Dermatol (in press)